Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (25,281,747) $ (21,661,311)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,186,396 1,645,759
Accretion of debt discount 26,225 30,076
Amortization of debt issuance costs 321,364 530,645
Capitalized paid-in-kind (PIK) interest 552,674 514,756
Accretion of exit fee, net of amount settled on conversion (63,055) 73,418
Stock-based compensation 757,224 968,240
Change in fair value of warrant liabilities (10,813) (145,738)
Change in fair value of November 2024 Debentures 1,065,112 128,122
Loss on extinguishment of debt 5,619,646 0
Change in fair value of derivative 157,000 0
Non-cash lease expense 281,970 294,324
Loss on disposal of assets 5,120 0
Changes in operating assets and liabilities:    
Accounts receivable (1,184,803) (1,003,549)
Inventories 0 41,146
Prepaid expense and other assets (392,395) 307,486
Accounts payable, accrued and other liabilities (999,116) (342,258)
Deferred revenue 191,406 0
Contract liabilities 0 (2,786)
Operating lease liabilities (320,867) (322,265)
Net cash used in operating activities (17,088,659) (18,943,935)
Cash flows from investing activities:    
Capital expenditures (146,267) (48,358)
Acquisition of business, net of cash acquired 0 (3,871,992)
Proceeds from sale of property and equipment 7,452 (500)
Net cash used in investing activities (138,815) (3,920,850)
Cash flows from financing activities:    
Proceeds from At the Market (ATM) offering, net 9,004,955 24,377,196
Proceeds from November 2024 Debentures 5,985,000 0
Proceeds from insurance financing 1,139,919 0
Issuance of Series B Preferred Stock 0 2,855,000
Repayment of AmeriState Loan (80,882) (61,108)
Repayment of insurance financing (866,115) 0
Net cash provided by financing activities 15,182,877 27,171,088
Net change in cash and cash equivalents (2,044,597) 4,306,303
Cash, cash equivalents and restricted cash, beginning of period 7,616,952 1,239,458
Cash, cash equivalents and restricted cash, end of period 5,572,356 5,545,761
Supplemental disclosure of cash flow information:    
Cash paid for interest 156,015 109,015
Series C Preferred Stock issued in exchange for November 2024 Debentures and Convertible Senior Secured Term Loan Notes 8,320,000  
Preferred stock dividend 705,845 0
Deemed dividend 9,718,751 3,427,706
ELOC Commitment Fee settlement in Common Stock 100,000 0
Earnout shares for acquisition 0 6,864,729
Debt assumed in acquisition 0 2,437,743
Accrued purchase price 0 3,655,086
Fair value of conversion of Term Loan notes and interest to Common Stock    
Supplemental disclosure of cash flow information:    
Conversion Of Convertible Debt To Common Stock 1,918,457 2,870,573
Series C Preferred Stock issued in exchange for November 2024 Debentures | Series C Preferred Stock    
Supplemental disclosure of cash flow information:    
Series C Preferred Stock issued in exchange for November 2024 Debentures and Convertible Senior Secured Term Loan Notes 3,659,502 0
Series C Preferred Stock issued in exchange for Convertible Senior Secured Term Loan Notes | Series C Preferred Stock    
Supplemental disclosure of cash flow information:    
Series C Preferred Stock issued in exchange for November 2024 Debentures and Convertible Senior Secured Term Loan Notes 8,320,000 0
Conversion of November 2024 Debentures to Common Stock    
Supplemental disclosure of cash flow information:    
Conversion Of Convertible Debt To Common Stock 283,790 0
Conversion of Series B Preferred Stock to Common Stock    
Supplemental disclosure of cash flow information:    
Series C Preferred Stock issued in exchange for November 2024 Debentures and Convertible Senior Secured Term Loan Notes 0  
Conversion of preferred to common stock 5 0
Conversion of Series C Preferred Stock to Common Stock    
Supplemental disclosure of cash flow information:    
Series C Preferred Stock issued in exchange for November 2024 Debentures and Convertible Senior Secured Term Loan Notes 0  
Conversion of preferred to common stock $ 22 $ 0